soul trial oral semaglutide cardiovascular outcomes results 2025 nejm and in Patients with Type 2 Diabetes Semaglutide cardiovascular outcomes align more
Description
Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in patients with type 2 diabetes (T2D)
It mimics naturally occurring hormone action in glucose regulation
IconSportswire.com: Millions of searchable sports photos
See how this medication helps patients achieve significant transformations.
